性铁的失调会使化学疗法耐药的癌细胞倾向于铁灭
Luke V Loftus1,2, Louis T A Rolle2, Bowen Wang2,3
1Cellular and Molecular Medicine Program, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA.
International journal of molecular sciences
|May 14, 2025
概括
耐化学反应的癌细胞表现出铁的失调,这种脆弱性可以通过诱导铁亡来利用. 准脂质过氧化防御均地使这些细胞对依赖铁的细胞死亡敏感.
科学领域:
- 在瘤学瘤学.
- 细胞死亡途径 细胞死亡途径
- 癌症治疗药物 耐药性 抗药性
背景情况:
- 转移性癌症在很大程度上是无法治愈的,原因是治疗耐药性.
- 铁亡,一种依赖于铁的细胞死亡,对抗抗性癌症有希望,但表现出可变的敏感性.
- 克服复发需要针对非扩散性漏洞的战略.
研究的目的:
- 为了确定化疗幸存癌细胞的常见漏洞.
- 为了研究铁在化学抵抗中的稳定作用.
- 探索铁亡作为耐化学性癌症的治疗策略.
主要方法:
- 在化学疗法幸存细胞中分析细胞表型和铁平衡.
- 研究NRF2信号及其对铁含量的影响.
- 选择性抑制GPX4以评估ferroptosis易感性.
主要成果:
- 化学疗法幸存者共享一种不调节铁平衡的表型,无论细胞类型或药物.
- 在幸存者中,升高的不稳定铁部分由NRF2信号控制,但没有得到解决.
- 抑制GPX4均地诱导这些幸存细胞中的铁亡,揭示了对脂质过氧化防御的依赖.
结论:
- 细胞铁失调是化学抵抗性癌细胞的保留漏洞.
- 通过抑制GPX4向铁死提供了一个潜在的战略,以克服化学抵抗.
- 通过诱导铁死来利用铁失调可能会改善癌症治疗结果.
相关概念视频
Necrosis
3.7K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
3.7K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Electron Transport Chain: Complex I and II
9.6K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
9.6K
Adaptive Mechanisms in Cancer Cells
5.6K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.6K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K


